secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempus AI, Inc. (TEM)
CIK:        0001717115
Form:       8-K
Filed at:   2025-11-04T23:59:59+00:00
Accession:  0001193125-25-264616
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tempus AI Q3 revenue $334M (+84.7% YoY); turns positive adjusted EBITDA; raises FY guidance
--------------------------------------------------------------------------------

- Revenue $334.2M, +84.7% YoY; gross profit $209.9M, +98.4% YoY.
- Adjusted EBITDA positive $1.5M vs ($21.8M) loss YoY; net loss ($80.0M) includes $35M stock comp and $12M debt extinguishment loss.
- Genomics revenue $252.9M (+117.2% YoY); Data and services $81.3M (+26.1%).
- 2025 revenue guidance raised to ~$1.265B (~80% growth); Q4 Adj. EBITDA expected ~$20M.
- Acquired Paige (AI digital pathology); 217k clinical tests delivered (+33% YoY).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1717115/000119312525264616/0001193125-25-264616-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1717115/000119312525264616/tem-20251104.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-264616

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer